Literature DB >> 18159555

Chlamydia pneumoniae and atherosclerosis: The end?

L E Nicolle1.   

Abstract

Entities:  

Year:  2005        PMID： 18159555      PMCID： PMC2095040          DOI： 10.1155/2005/617308

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  4 in total

Review 1.  Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.

Authors:  John P Higgins
Journal:  Mayo Clin Proc       Date:  2003-03       Impact factor: 7.616

Review 2.  Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.

Authors:  J Ngeh; V Anand; S Gupta
Journal:  Clin Microbiol Infect       Date:  2002-01       Impact factor: 8.067

Review 3.  Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.

Authors:  Richard Andraws; Jeffrey S Berger; David L Brown
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

Review 4.  Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials.

Authors:  Catherine Liu; David D Waters
Journal:  Prog Cardiovasc Dis       Date:  2005 Jan-Feb       Impact factor: 8.194
  4 in total
  3 in total

Review 1.  Bacterial invasion of vascular cell types: vascular infectology and atherogenesis.

Authors:  Emil Kozarov
Journal:  Future Cardiol       Date:  2012-01

2.  Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis.

Authors:  Vladimir M Subbotin
Journal:  Theor Biol Med Model       Date:  2012-04-10       Impact factor: 2.432

3.  Association of plasma circulatory markers, Chlamydia pneumoniae, and high sensitive C-reactive protein in coronary artery disease patients of India.

Authors:  Hem Chandra Jha; Pragya Srivastava; Rakesh Sarkar; Jagdish Prasad; Aruna Singh Mittal
Journal:  Mediators Inflamm       Date:  2009-04-05       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.